Hemopressin

Hemopressin is a bioactive peptide derived from the alpha chain of hemoglobin. It is known to act as an inverse agonist of the CB1 cannabinoid receptor, which is the same receptor that the active components of cannabis act upon. Hemopressin has been found to have potential therapeutic applications in the treatment of pain, inflammation, and possibly even obesity.

Structure and Function

Hemopressin is a nonapeptide, meaning it is composed of nine amino acids. Its sequence is PVNFKFLSH, and it is derived from the alpha chain of hemoglobin, specifically the 32-40 region. Hemopressin is unique among peptides in that it is not processed from a larger precursor protein, but is instead directly cleaved from hemoglobin.

Hemopressin acts as an inverse agonist of the CB1 cannabinoid receptor. This means that it binds to the receptor and induces the opposite effect of an agonist. In the case of the CB1 receptor, this means that hemopressin reduces the activity of the receptor, which is associated with a decrease in appetite, pain sensation, and inflammation.

Therapeutic Applications

Due to its action on the CB1 receptor, hemopressin has potential therapeutic applications in a number of areas. It has been found to have analgesic effects in animal models, suggesting it could be used in the treatment of pain. It also has anti-inflammatory effects, which could make it useful in the treatment of conditions such as arthritis.

In addition, hemopressin has been found to reduce food intake in animals, suggesting it could potentially be used in the treatment of obesity. However, more research is needed to fully understand the potential therapeutic applications of hemopressin.

See Also

• Cannabinoid receptor
• Hemoglobin
• Peptide

References

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

Hemopressin

• 

  Hemopressin